Dulera side effects depression

Dulera

SIDE EFFECTS

LABA use may result in the following:

  • Serious asthma-related events – hospitalizations, intubations, and death .
  • Cardiovascular and central nervous system effects .

Systemic and local corticosteroid use may result in the following:

  • Candida albicans infection
  • Immunosuppression
  • Hypercorticism and adrenal suppression
  • Growth effects in pediatrics
  • Glaucoma and cataracts

Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

Clinical Trials Experience

The safety data described below is based on 3 clinical trials which randomized 1913 patients 12 years of age and older with asthma, including 679 patients exposed to DULERA for 12 to 26 weeks and 271 patients exposed for 1 year. DULERA was studied in two placebo-and active-controlled trials (n=781 and n=728, respectively) and in a long-term 52-week safety trial (n=404). In the 12 to 26week clinical trials, the population was 12 to 84 years of age, 41% male and 59% female, 73% Caucasians, 27% non-Caucasians. Patients received two inhalations twice daily of DULERA (100 mcg/5 mcg or 200 mcg/5 mcg), mometasone furoate MDI (100 mcg or 200 mcg), formoterol MDI (5 mcg) or placebo. In the long-term 52-week active-comparator safety trial, the population was 12 years to 75 years of age with asthma, 37% male and 63% female, 47% Caucasians, 53% non-Caucasians and received two inhalations twice daily of DULERA 100 mcg/5 mcg or 200 mcg/5 mcg, or an active comparator.

The incidence of treatment emergent adverse reactions associated with DULERA in Table 2 below is based upon pooled data from 2 clinical trials 12 to 26 weeks in duration in patients 12 years and older treated with two inhalations twice daily of DULERA (100 mcg/5 mcg or 200 mcg/5 mcg), mometasone furoate MDI (100 mcg or 200 mcg), formoterol MDI (5mcg) or placebo.

Table 2: Treatment-Emergent Adverse Reactions in DULERA Groups Occurring at an Incidence of ≥3% and More Commonly than Placebo

Oral candidiasis has been reported in clinical trials at an incidence of 0.7% in patients using DULERA 100 mcg/5 mcg, 0.8% in patients using DULERA 200 mcg/5 mcg and 0.5% in the placebo group.

Long-Term Clinical Trial Experience

In a long-term safety trial in patients 12 years and older treated for 52 weeks with DULERA 100 mcg/5 mcg (n=141), DULERA 200 mcg/5 mcg (n=130) or an active comparator (n=133), safety outcomes in general were similar to those observed in the shorter 12 to 26 week controlled trials. No asthma-related deaths were observed. Dysphonia was observed at a higher frequency in the longer term treatment trial at a reported incidence of 7/141 (5%) patients receiving DULERA 100 mcg/5 mcg and 5/130 (3.8%) patients receiving DULERA 200 mcg/5 mcg. No clinically significant changes in blood chemistry, hematology, or ECG were observed.

Postmarketing Experience

The following adverse reactions have been reported during post-approval use of DULERA or post-approval use with inhaled mometasone furoate or inhaled formoterol fumarate. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Cardiac disorders: angina pectoris, cardiac arrhythmias, e.g., atrial fibrillation, ventricular extrasystoles, tachyarrhythmia Immune system disorders: immediate and delayed hypersensitivity reactions including anaphylactic reaction, angioedema, severe hypotension, rash, pruritus

Investigations: electrocardiogram QT prolonged, blood pressure increased (including hypertension)

Metabolism and nutrition disorders: hypokalemia, hyperglycemia

Respiratory, thoracic and mediastinal disorders: asthma aggravation, which may include cough, dyspnea, wheezing and bronchospasm

Read the entire FDA prescribing information for Dulera (Mometasone Furoate, Formoterol Fumarate Dihydrate Inhalation)

Dulera is a prescription inhaler used to control and prevent symptoms of asthma in people age 12 years and older.

DULERA combines the inhaled corticosteroid medication known as mometasone furoate and a long-acting beta2-agonist medication (LABA) known as formoterol. Inhaled corticosteroids help decrease inflammation in the lungs, and LABA drugs help relax muscles around the airways in your lungs.

The drug is manufactured by Merck and Co., Inc., and was approved by the Food and Drug Administration (FDA) in 2010.

In a study of asthma patients, those using Dulera experienced a significant improvement in lung function. Over six months, 70 percent of patients taking Dulera did not have an asthma flare-up, compared to 66 percent taking mometasone furoate, 46 percent taking formoterol alone, and 44 percent of patients using a placebo inhaler.

Dulera Warnings

Dulera should not be used as a rescue inhaler, and it should not be used in patients whose asthma is well controlled with other medicines, or those who only need a rescue inhaler occasionally.

Clinical trials have shown that people with asthma that take LABA medicines such as formoterol, which is one of the ingredients in Dulera, have an increased risk of asthma-related death. It is not known whether the other medicine in Dulera, mometasone furoate, affects the risk of death from asthma problems seen with formoterol.

You should seek emergency medical care if your breathing problems worsen quickly and your rescue inhaler does not offer relief while taking Dulera.

It is not known whether Dulera is safe or effective in children under age 12. Children and adolescents who take LABA medicines may have an increased risk of being hospitalized for asthma-related problems.

You should tell your health care provider about all of your health conditions before taking Dulera. It is not known whether this medication will harm an unborn or nursing baby. You should tell your doctor if you are pregnant or nursing while taking this drug.

Do not use Dulera more often than prescribed, and do not use it with other medicines that contain a LABA. Too much LABA can cause the following symptoms:

  • Chest pain
  • An increase or decrease in blood pressure
  • Fast or irregular heartbeat
  • Headache
  • Tremor
  • Nervousness
  • Dizziness
  • Weakness
  • Seizures
  • Electrocardiogram changes

If you are switching from an oral corticosteroid to Dulera, you should follow your doctor’s instructions carefully to avoid serious health risks. You should not change or stop using this medication unless directed by your doctor.

When your asthma is well controlled, your doctor may tell you to stop taking Dulera and may prescribe a different, long-term asthma medicine.

What are the side effects of Dulera?

The most common side effects of the asthma medication Dulera (mometasone and formoterol) are swelling and irritation of the nose, throat and/or sinuses and headaches. You should call your doctor if you develop any of the following symptoms while taking Dulera:

  • signs of oral thrush including white patches in your mouth or on your tongue, cracking at the corners of your mouth, redness or soreness in your mouth or difficulty swallowing
  • signs of infection including fever, fatigue, pain, nausea, vomiting, body aches or chills
  • symptoms of adrenal insufficiency including chronic worsening fatigue, muscle weakness, loss of appetite, weight loss, salty food cravings, irregular or absent menstrual periods (in women), sweating, irritability or depression, dizziness or fainting, nausea, vomiting or diarrhea
  • increased wheezing, especially right after taking Dulera
  • symptoms caused by taking too much of a LABA medicine including chest pain, fast or irregular heartbeat, increased or decreased blood pressure, tremor, nervousness, seizures, weakness, dizziness or headache

Over time, Dulera may cause long-term side effects, and your doctor may want to monitor you closely for them. These problems may include:

  • reduced bone mineral density
  • eye problems, including cataracts and glaucoma. Follow your doctor’s guidelines for getting eye exams while you are taking Dulera.
  • decreases in blood potassium levels (hypokalemia)
  • increases in blood sugar levels (hyperglycemia)
  • slowed growth (in children)

People with asthma who take LABAs have an increased risk of death from asthma. Call your doctor if your asthma symptoms worsen when you take Dulera, and call 911 if your breathing problems worsen quickly and/or your rescue inhaler doesn’t relieve your breathing problem. Call for emergency medical help also if you suffer symptoms of an allergic reaction: rash, hives, trouble breathing or swelling of your face, mouth, or tongue.

Combination inhalers prescribed for asthma, smoking lung disease (COPD), or persistent cough after an upper respiratory infection are some of the top selling drugs in the United States. Several steroid + long acting bronchodilator combinations are currently available: the older Advair and Symbicort and the newer Dulera and Breo Ellipta.

While Advair and Symbicort are recommended for treatment of both moderate persistent asthma and COPD, Breo has been introduced with the indication for COPD treatment only. Which combo inhaler you are prescribed is often based on your insurance coverage because while they differ in delivery mechanism, they generally work just as well.

If you have similar insurance coverage for Advair, Symbicort, Dulera, or Breo, you may want to consider the commonly reported side effects:

  1. Voice changes. Hoarseness or huskiness are common symptoms, related to the steroid component of the inhaler. Voice changes occur in 5 to 10% of people and are more common with frequent use and with fluticasone (in the Advair) compared to other steroids. Rinsing your mouth by gargling with water will help remove the locally deposited steroid in the mouth (not where you want it, you want it in the lungs). It has been shown that 56% of the dose from your inhaler is deposited in the mouth/throat and a mouth rinse promptly can remove 60% of this residue.
  2. Yeast infections of the mouth/thrush. The steroid in your combo inhaler may cause candidiasis (yeast) infection in the mouth as a potential side effect. This will look like white, soft plaques that leave a painful red, eroded, or ulcerated surface. The sides of the tongue, back of throat and inside the cheek are common sites where you may notice tenderness, burning, and pain with swallowing. The antifungal mouthwash Nystatin can be used to treat this.
  3. Cavities (dental caries) from dry mouth. Dry mouth and increased thirst is reported with the combination inhalers. The bronchodilator part of the inhaler (beta-2 agonist) is associated with the increased frequency of cavities. Long term use of beta-2 agonists is associated with diminished saliva production and secretion.
  4. Pneumonia. This may be the case only with the steroid in Advair (fluticasone) and not with Symbicort (budesonide). The use of Advair has been associated with a higher prevalence of pneumonia in the major long-term studies, but no similar increased risk of pneumonia has been reported in patients with COPD treated with Symbicort. This difference may be explained by the longer retention of fluticasone in the airways.
  5. Headache. 7% to 11% of folks using these combination inhalers report headaches.
  6. Cough. While we don’t know exactly why this occurs, cough may be a result of throat irritation from the inhaler.
  7. Throat pain. Even without thrush, pain and soreness in the throat is reported in 6 to 9% of folks using these combination inhalers.
  8. Adrenocortical suppression. Side effects like this are unlikely to occur at prescribed doses of the newer inhalers unless you are using them long term. With long term use of inhaled steroids at high doses you can suppress your own production of certain hormones (cortisol). Abruptly discontinuing your inhaler may lead to serious symptoms like extreme fatigue and low blood pressure.
  9. Osteoporosis and bone fractures. Steroids stimulate the process of bone turnover but at doses lower than 800 mcg a day this is unlikely to occur. Long term use of inhaled steroids (half of the contents of your combination inhaler) may lead to brittle bones and increased risk of spine and hip fractures. For reassurance you can look at your inhaler for the dose of steroid it contains: for example Advair 250 mcg/50 mcg contains 250 mcg of the steroid fluticasone.
  10. Skin thinning and purpura (purple spots on the skin, most commonly arms). Long term use of the steroid in your combo inhaler leads to loss of subcutaneous fat. Skin bruising and purple spots may happen with long term combination inhaler use.

One last note on weaning off and discontinuing Advair, Symbicort, Dulera or Breo:

An interesting fact—inhaled corticosteroids, particularly fluticasone, are absorbed more (meaning more chance for unwanted systemic side effects) in folks with normal lung function. This is a reminder that you should step down the inhaled steroid dose/combo inhaler once your breathing from asthma or COPD is adequately controlled.

Dr O.

Put drug prices & coupons in your pocket! We’ll text you a link to download our free Android or iPhone app Get GoodRx Mobile App Your link is on the way!

We’ve sent a link to download the GoodRx mobile app to your phone.

Something went wrong

We were unable to send a link to your phone.

  • Dulera inhaler linked to adrenocorticotropic suppression in small case series

    ORLANDO – A combination corticosteroid asthma inhaler has, for the first time, been associated with growth delay and adrenocorticotropic suppression in children.

    The single-center case series is small, but the results highlight the need to regularly monitor growth and adrenal function in children using inhaled mometasone furoate/formoterol fumarate (Dulera; Merck), investigators said at the annual meeting of the Endocrine Society.

    “We are hoping to raise awareness of this risk in our pediatric endocrinology colleagues, as well as among allergists, pulmonologists, and pediatricians who treat these children,” said Fadi Al Muhaisen, MD. “These kids should be regularly screened for growth delay and adrenal insufficiency and have their growth plotted at every visit as well.”

    Michele G. Sullivan/Frontline Medical News

    Dr. Fadi Al Muhaisen and Dr. Jennifer Boyd

    Dr. Al Muhaisen and his colleague, Jennifer Boyd, DO, work together in the pediatric endocrinology division at Children’s Mercy Hospital, Kansas City, Mo. “We noticed that we had been seeing children in our endocrinology clinic for adrenal insufficiency, and that a number of them were on this medication. That prompted us to conduct a chart review,” of patients seen there from 2008 to 2016.

    Dulera was approved in the United States in 2010 as a maintenance therapy for chronic asthma in adults and children aged 12 years and older. Mometasone furoate is a potent corticosteroid, and formoterol fumarate is a long-acting beta2-adrenergic agonist. The prescribing information says that mometasone furoate exerts less effect on the hypothalamic-pituitary-adrenal axis than other inhaled corticosteroids, and that adrenal suppression is unlikely to occur when used at recommended dosages. These range from a low of 100 mcg/5 mcg, two puffs daily to a maximum dose of 800 mcg/20 mcg daily.

    The review involved 18 children, all of whom were seen in the endocrinology clinic for growth failure or short stature and were receiving Dulera for management of their asthma. Of these, eight (44%) had a full adrenal evaluation. Six had biochemical evidence of adrenal suppression and two had normal adrenal function. The remaining 10 patients had not undergone an adrenal evaluation. None of them were on any other inhaled corticosteroid. The six children diagnosed with adrenal insufficiency had a mean age of 9.7 years, but ranged in age from 7 to 12 years. They had been using the medication for a mean of 1.3 years, although that varied widely, from just a few months to about 2 years. Only one had been on oral steroids in the preceding 6 months before coming to the endocrinology clinic. Five were using the 200 mcg/5 mcg dose, two puffs daily; one child was taking one puff daily of 100 mcg/5 mcg at the time of diagnosis but had been using the higher dose for the preceding 18 months. Three were using concomitant nasal steroids.

    The six children evaluated had been using the medication for a mean of 1.3 years, although that varied widely, from just a few months to about 2 years. Only one had been on oral steroids during the 2 years before coming to the endocrinology clinic. Five were using the 200 mcg/5 mcg dose, two puffs daily; one child was taking one puff daily of 100 mcg/5 mcg at time of diagnosis, but had been using the higher dose for 18 months before that. Three were using concomitant nasal steroids.

    All presented with growth failure, with bone age 1-3 years behind chronological age. One child was referred to the clinic after an emergency department visit for headache, nausea, diarrhea, and fatigue – symptoms of adrenal failure. That child had an adrenocroticotropin (ACTH) level of 10 pg/mL. Both his random peak cortisol measures after ACTH stimulation were less than 1 mcg/mL.

    ACTH levels in four of the children were less than 5-6 pg/ml, with random and peak stimulated cortisols of around 1 mcg/mL. One patient had an ACTH level of 68 pg/mL, a random cortisol of less than 1 mcg/mL, and a peak stimulated cortisol of 8.7 mcg/mL.

    All of the children were weaned from Dulera. During and after weaning, five were put on a maintenance dose of oral steroids (8-19 mg/m2), with increased dosage in times of physiological stress. One patient was not put on a maintenance steroid but was given steroids for use during stress periods.

    The results were all normal in the four subjects who had repeat adrenal function evaluation after intervention. Adrenal recovery took a mean of 20 months (5-30 months).

    Growth accelerated rapidly after intervention, which was either initiation of maintenance oral steroids and discontinuation of Dulera or, in one patient, after Dulera was weaned. At time of adrenal insufficiency diagnosis, four patients had grown 1-2 cm in the prior year; one had not grown at all, and one had grown about 4.5 cm. After discontinuing or weaning the medication, all experienced growth spurts: 3 cm/year in 6 months; 8 cm/year in 22 months; 6 cm/year in 5 months; 8 cm/year in 12 months; 5 cm/year in 5 months; and 10 cm/year in 7 months.

    There were no exacerbations in asthma, despite discontinuing the inhaled medication, Dr. Al Muhaisen said. Changing the asthma treatment required some open discussion between the investigators and the treating pulmonologists, he noted.

    “We had some back-and-forth discussions, being very frank that we thought the adrenal insufficiency was directly related to this medication and that we needed to wean it and stop it as soon as possible.”

    Neither Dr. Al Muhaisen nor Dr. Boyd had any financial disclosures.

    [email protected]

    Dulera Inhaler

    Generic Name: formoterol and mometasone (for MOE ter ol and moe MET a sone)
    Brand Names: Dulera

    Medically reviewed by P. Thornton, DipPharm Last updated on Nov 5, 2019.

    • Overview
    • Side Effects
    • Dosage
    • Professional
    • Interactions
    • More

    What is Dulera?

    Dulera inhalers contain a combination of formoterol and mometasone. Formoterol is a long-acting bronchodilator that relaxes muscles in the airways to improve breathing.< Mometasone is a corticosteroid. It prevents the release of substances in the body that cause inflammation.

    Dulera is used to control and prevent the symptoms of asthma in adults and children who are at least 5 years old.

    Dulera is not for use in treating an asthma or bronchospasm attack.

    Important Information

    Dulera is not a rescue medicine for asthma attacks. It will not work fast enough to treat an asthma or bronchospasm attack.

    Formoterol when used alone may increase the risk of death in people with asthma. However, this risk is not increased when formoterol and mometasone are used together as a combination product.

    Seek medical attention if your breathing problems get worse quickly, or if you think your asthma medications are not working as well.

    Before taking this medicine

    You should not use Dulera if you are allergic to formoterol or mometasone.

    Mometasone can weaken your immune system. Tell your doctor about any illness or infection you’ve had within the past several weeks.

    To make sure Dulera is safe for you, tell your doctor if you have ever had:

    • heart disease, high blood pressure;

    • a seizure;

    • a weak immune system;

    • liver disease;

    • osteoporosis;

    • glaucoma, cataracts, or other vision problems;

    • diabetes;

    • a drug allergy;

    • pheochromocytoma (tumor of the adrenal gland);

    • a thyroid disorder; or

    • an aneurysm (a weakened or damaged blood vessel that could tear and cause severe bleeding).

    Tell your doctor if you are pregnant. It is not known whether formoterol and mometasone will harm an unborn baby. However, having untreated or uncontrolled asthma during pregnancy may cause complications such as low birth weight, premature birth, or eclampsia (dangerously high blood pressure that can lead to medical problems in both mother and baby). The benefit of treating asthma may outweigh any risks to the baby.

    It may not be safe to breastfeed while using this medicine. Ask your doctor about any risk.

    Dulera is not approved for use by anyone younger than 5 years old.

    How should I use Dulera?

    Dulera inhalers come with patient instructions for safe and effective use, and directions for priming the inhaler device. Follow these directions carefully. Use the medicine exactly as directed. Using too much of this medicine can cause life-threatening side effects. Ask your doctor or pharmacist if you have any questions.

    Dulera is not a rescue medicine for asthma attacks. Use only fast-acting inhalation medicine for an attack. Seek medical attention if your breathing problems get worse quickly, or if you think your asthma medications are not working as well.

    Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you do not understand these instructions.

    Rinse your mouth with water without swallowing after each use of your Dulera inhaler.

    Do not allow a young child to use this medicine without help from an adult.

    It may take up to 1 or 2 weekss before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve. Your doctor may tell you to stop using Dulera once your asthma is well controlled.

    Your dose needs may change due to surgery, illness, stress, or a recent asthma attack. Do not change your medication dose or schedule without your doctor’s advice.

    If you use a peak flow meter at home, tell your doctor if your numbers are lower than normal.

    Your vision and your bone mineral density may need to be checked often.

    Store at room temperature away from moisture and high heat. The canister may explode if it gets too hot. Do not puncture or burn an empty inhaler canister.

    The 120-inhalation Dulera inhaler does not require specific storage orientation. For the 60-inhalation Dulera inhaler, after priming, store the inhaler with the mouthpiece down or on its side. Keep the medicine canister away from open flame or high heat, such as in a car on a hot day. The canister may explode if it gets too hot. Do not puncture or burn an empty inhaler canister.

    Once your asthma is under control, your doctor may want you to stop using this medicine. Do not stop using the medicine unless your doctor tells you to.

    Dulera dosing information

    Usual Adult Dose of Dulera for Asthma — Maintenance:

    Two inhalations inhaled orally twice daily (morning and evening).
    Each inhalation contains either 100 mcg or 200 mcg of mometasone with 5 mcg of formoterol.
    Maximum Daily Dose: 800 mcg of mometasone; 20 mcg of formoterol

    -The starting dose should be determined based on patient’s previous asthma therapy.
    -Patients previously on inhaled medium dose corticosteroids should be started on the 100 mcg/5 mcg strength.
    -Patients previously on inhaled high dose corticosteroids should be started on the 200 mcg/5 mcg strength.
    -Not for use in treatment of acute bronchospasm.

    Usual Pediatric Dose for Asthma — Maintenance:

    For children 12 years of age and older:
    Two inhalations inhaled orally twice daily (morning and evening).
    Each inhalation contains either 100 mcg or 200 mcg of mometasone with 5 mcg of formoterol.
    Maximum Daily Dose: 800 mcg of mometasone; 20 mcg of formoterol

    -The starting dose should be determined based on patient’s previous asthma therapy.
    -Patients previously on inhaled medium dose corticosteroids should be started on the 100 mcg/5 mcg strength.
    -Patients previously on inhaled high dose corticosteroids should be started on the 200 mcg/5 mcg strength.
    -Not for use in treatment of acute bronchospasm.
    Use: Indicated for patients 12 years of age and older who have inadequate control on a long-term asthma control medication or whose disease severity requires initiation of an inhaled corticosteroid and long-acting beta2-adrenergic agonist

    What happens if I miss a dose?

    Skip the missed dose and use your next dose at the regular time. Do not use two doses at one time.

    What happens if I overdose?

    Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

    Overdose symptoms may include chest pain, fast heart rate, and feeling shaky or short of breath.

    What should I avoid while using Dulera?

    Do not use a second inhaled bronchodilator that contains formoterol or a similar medicine (such as arformoterol, indacaterol, olodaterol, salmeterol, or vilanterol).

    Avoid being near people who are sick or have infections. Call your doctor for preventive treatment if you are exposed to chickenpox or measles. These conditions can be serious or even fatal in people who are using a medicine that contains mometasone (a steroid).

    Dulera side effects

    Get emergency medical help if you have signs of an allergic reaction to Dulera: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.

    Call your doctor at once if you have:

    • worsening asthma symptoms;

    • tremors, nervousness, chest pain, fast or pounding heartbeats;

    • fever, chills, cough with mucus, feeling short of breath;

    • wheezing, choking, or other breathing problems after using this medication;

    • blurred vision, tunnel vision, eye pain or redness, or seeing halos around lights;

    • signs of thrush (a fungal infection) – sores or white patches in your mouth or throat, trouble swallowing;

    • high blood sugar – increased thirst, increased urination, dry mouth, fruity breath odor;

    • low potassium level – leg cramps, constipation, irregular heartbeats, fluttering in your chest, numbness or tingling, muscle weakness or limp feeling; or

    • signs of a hormonal disorder – tiredness or weakness, feeling light-headed, nausea, vomiting.

    Mometasone can affect growth in children. Tell your doctor if your child is not growing at a normal rate while using this medicine.

    Common Dulera side effects may include:

    • runny or stuffy nose, sinus pain;

    • headache; or

    • cough, sore throat.

    This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

    What other drugs will affect Dulera?

    Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.

    Tell your doctor about all your other medicines, especially:

    • antifungal medicine such as ketoconazole; or

    • medicine to treat HIV (especially if it contains cobicistat, lopinavir, or ritonavir).

    This list is not complete. Other drugs may interact with formoterol and mometasone, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.

    Further information

    Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Dulera only for the indication prescribed.

    Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

    Copyright 1996-2020 Cerner Multum, Inc. Version: 12.01.

    Medical Disclaimer

    More about Dulera (formoterol / mometasone)

    • Side Effects
    • During Pregnancy
    • Dosage Information
    • Drug Interactions
    • Support Group
    • Pricing & Coupons
    • En Español
    • 50 Reviews
    • Drug class: bronchodilator combinations
    • FDA Alerts (2)
    • FDA Approval History

    Consumer resources

    • Dulera
    • Dulera (Advanced Reading)

    Professional resources

    • Dulera (FDA)

    Related treatment guides

    • Asthma
    • Asthma, Maintenance

About the author

Leave a Reply

Your email address will not be published. Required fields are marked *